Pravin Dugel Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 1 week ago
Pravin Dugel has an estimated net worth of at least $39.0 million*, as of Oct. 29, 2025. They own 3.3 million shares of OCUL stock. They have sold 127,374 shares of OCUL stock since 2021, for an estimated $1.1 million.
Pravin Dugel $OCUL SEC Form 4 Insider Trading
Pravin Dugel has filed a total of 6 insider trades in $OCUL since 2021. Their most recent trade was a sale of 21,494 shares, made on Aug 25, 2025. Their largest trade was a sale of 21,626 shares, made on May 23, 2024. We estimate that they now own 3.3 million shares of $OCUL, worth an estimated $37.9 million.
Insider Trading at $OCUL
There have been a total of 72 insider trades reported at $OCUL since 2021, with 3.0 million shares purchased and 386,477 shares sold. The most active insider traders in $OCUL stock have been Pravin Dugel, Sanjay Nayak, and Antony C. Mattessich. The most recent trade was a sale of 25,865 shares reported by Namrata Saroj (Chief Business Officer), made on Nov 05, 2025.
History of Insider Stock Trades by Pravin Dugel
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
OCUL
|
Sale | 21,494 | Aug 25, 2025 | Aug. 27, 2025, 6:41 p.m. |
|
OCUL
|
Sale | 21,219 | May 23, 2025 | May 27, 2025, 5:37 p.m. |
|
OCUL
|
Sale | 21,475 | Feb 24, 2025 | Feb. 26, 2025, 7:27 p.m. |
|
OCUL
|
Sale | 20,680 | Nov 25, 2024 | Nov. 27, 2024, 8:47 a.m. |
|
OCUL
|
Sale | 20,880 | Aug 23, 2024 | Aug. 27, 2024, 5:17 p.m. |
|
OCUL
|
Sale | 21,626 | May 23, 2024 | May 28, 2024, 5 p.m. |
$OCUL Executives and Stock Owners with Insider Trades
-
Pravin Dugel, See Remarks
-
Sanjay Nayak, Chief Strategy Officer
-
Antony C. Mattessich, President and CEO
-
Jeffrey S. Heier, Chief Scientific Officer
-
Peter Kaiser, Chief Development Officer
-
Rabia Gurses Ozden, Chief Medical Officer
-
Christopher G White, Chief Business Officer
-
Donald Notman, Chief Financial Officer
-
Donald Notman, See Remarks
-
Philip C. Strassburger, General Counsel
-
Nadia Waheed, Chief Medical Officer
-
Namrata Saroj, Chief Business Officer
-
Todd Anderman, Chief Legal Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.